行业新闻
关注特色分子砌块、偶联化学、工艺问题和材料选择相关内容
全部新闻
共 58 篇文章
Stepwise Disulfide Bond Construction in Peptides: Orthogonal Protection Meets Regioselective Folding
When a peptide carries two, three, or four disulfide bonds, the question is not whether cysteines can be oxidized — it is whether they pair correctly. Orthogonal protection answers this by assigning each cysteine pair a protecting group removable under conditions that leave the others intact. The most widely used group in Fmoc-SPPS is trityl (Trt), which cleaves with 1–5% TFA and is the default for single-disulfide peptides. But Trt alone cannot support regioselective multi-disulfide assembly.
Reported SPPS Resin Selection Criteria for Peptide Process Work
For a peptide process team, resin selection is a design decision made before the first coupling cycle. The reported selection model starts with the C-terminal functional group needed after cleavage, then checks whether the sequence raises risks such as diketopiperazine formation, racemization, steric hindrance, poor swelling, or a need for protected fragments.
Generative AI Meets Peptide Chemistry: How ApexGO Frames Peptide Lead Optimization
Antimicrobial resistance continues to drive interest in peptide-based antibiotics as an alternative to conventional small molecules. However, optimizing peptide leads for activity, selectivity, and stability can require repeated synthesis, purification, and assay cycles. Each round consumes time and material, limiting how many candidates can be explored experimentally.
Ten Key Peptide Modifications: Chemistry and Implications for Custom Synthesis
Peptide modification chemistry changes the functional groups attached to a peptide or protein scaffold. For R&D and CDMO teams, the practical question is not only which modification appears on a sequence; it is where the modification sits, whether it survives the route, how it changes purification, and which analytical methods can distinguish intended material from close impurities.
Reported 2026 ASCO ADC Themes: Design Control for New Formats
The reported 2026 ASCO education-session themes frame next-generation antibody-drug conjugate work around engineering variables: target engagement, payload pairing, payload novelty, DAR design, and dose strategy. For CHEMOS readers, the useful point is not that any format has been proven superior. It is that each new ADC format moves more risk into linker-payload synthesis, conjugation control, analytical methods, formulation assumptions, and evidence discipline.
Cancer Cell Review Links ADC Performance to Tumor Ecosystem Biology
The practical message from the Cancer Cell review is that an antibody-drug conjugate cannot be evaluated by target presence alone. An ADC must bind an antigen, reach the relevant intracellular trafficking route, release a payload in the intended compartment, and be assessed in the tumor and patient context described by the review. That makes precision ADC development a combined biology, chemistry, and analytics problem.